For second consecutive year, the pharmaceutical laboratory appears on the CEPYME500 list, prepared by CEPYME, Spanish Confederation of Small and Medium Enterprises, which selects a total of 500 national companies from different sectors.
HC Clover PS has been selected for its growth plan. During the last year, the laboratory has increased its production capacity by 27% reaching 1,800 million capsules per year and has expanded its facilities to 7,000 m2. It has more than 230 employees and, in turn, generates more than 600 indirect jobs. Its sales exceed 26 million euros, which means an annual growth rate of more than 14%.
In addition, HC Clover PS has completed the second phase of this growth plan with the opening of a new production plant for soft gelatine capsules for food supplements in Brazil. Previously, Gramar Laboratorios was acquired and increased production capacity with the inauguration of the sixth line of encapsulation, which joins the arrival of the laboratory to the Asian market.